Mature dendritic cells boost functionally superior CD8+ T-cell in humans without foreign helper epitopes

Journal of Clinical Investigation

Volumn 105, Issue 6, 2000, Pages

  Dhodapkar, Madhav V ^a   Krasovsky, Joseph ^a   Steinman, Ralph M ^a   Bhardwaj, Nina ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; KEYHOLE LIMPET HEMOCYANIN; MATRIX PROTEIN; TETANUS TOXOID;

ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EFFECTOR CELL; HELPER CELL; HUMAN; HUMAN CELL; IMMUNIZATION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0034023485     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI9051     Document Type: Article

References (15)

1. Raychaudhuri, S., and Rock, K.L. 1998. Fully mobilizing host defense: building better vaccines. Nat. Biotechnol. 16:1025-1031.
2. Banchereau, J., and Steinman, R.M. 1998. Dendritic cells and the control of immunity. Nature. 392:245-252.
3. Dhodapkar, M.V., et al. 1999. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J. Clin. Invest. 104:173-180.
4. Murphy, G., Tjoa, H., Ragde, H., Kenny, G., and Boynton, A. 1996. Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A020-specific peptides from prostate-specific peptides from prostate-specific membrane antigen Prostate. 29:371-380.
5. Nestle, F.O., et al. 1998. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat. Med. 4:328-332.
6. Holtl, L., et al. 1999. Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells. J. Urol. 161:777-782.
7. Ludewig, B., et al. 1999. Protective antiviral cytotoxic T cell memory is most efficiently maintained by restimulation via dendritic cells. J. Immunol. 163:1839-1844.
8. - T-helper and a T-killer cell. Nature. 393:474-478.
9. + T cells. J. Clin. Invest. 94:797-807.
10. Livingstone, A.M., and Kuhn, M. 1999. Dendritic cells need T cell help to prime cytotoxic T cell responses to strong antigens. Eur. J. Immunol. 29:2826-2834.
11. Bachmann, M.F., Speiser, D.E., and Ohashi, P.S. 1997. Functional maturation of antiviral T cell response. J. Virol. 71:5764-5768.
12. Busch, D H., and Pamer, E.G. 1999. T cell affinity maturation by selective expansion during infection. J. Exp. Med. 189:701-710.
13. Savage, P.A., Boniface, J.J., and Davis, M.M. 1999. A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity. 10:485-492.
14. Alexander-Miller, M.A., Leggart, G.R., and Berzofsky, J.A. 1996. Selective expansion of high-or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc Natl. Acad. Sci. USA. 93:4102-4107.
15. Zeh, H.J., III, Perry-Lalley, D., Dudley, M.E., Rosenberg, S.A., and Yang, J.C. 1999. High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy. J. Immunol. 162:989-994.